Chris Dokomajilar is the founder and CEO of DealForma, the biopharma deals database and custom analytics service providing benchmarking data for licensing and funding. Prior to founding DealForma, Chris held research, management consulting, and industry analytics roles within biopharma and academia at Recap, Deloitte, Thomson Reuters, BioCentury, and the University of California San Francisco. He enjoys the opportunity to contribute to industry thought-leadership and is frequently invited to speak to industry groups about biopharma business development, licensing, and finance. Chris holds molecular biology degrees from the University of California Berkeley.